New York and more than two dozen other US states sued 23andMe to challenge the sale of its customers’ private information ...

The DNA of 15 million people was sold after 23andMe filed for bankruptcy and was acquired by pharmaceutical giant Regeneron. Concerns about the use of this genetic data have prompted New York Attorney ...

Lawmakers raised questions and concerns about the sale of genetic-testing company 23andMe during a hearing on Tuesday.

The bipartisan lawsuit was filed on Monday in St. Louis alongside a separate objection to the bankruptcy sale and is being ...

Over half of all U.S. states are suing to block the sale of 23andMe's personal genetic data, which would be done without ...

PORTLAND, Ore. (AP) — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking ...

More than two dozen states, along with the District of Columbia, are suing biotechnology company 23andMe over plans to ...

A group of attorneys general from 27 states and the District of Columbia is suing 23andMe (OTC:MEHCQ) to prevent the bankrupt ...

The genetic-testing company, which collected DNA data from users, is for sale in bankruptcy court. Now, 27 states and the ...

Twenty-seven states, including Illinois and Wisconsin, and the District of Columbia on Monday filed a lawsuit in bankruptcy ...

State attorneys general are seeking a ruling in 23andMe’s bankruptcy that the DNA-testing firm needs explicit consent from customers before transferring their genetic data to another company.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) 46th Annual Goldman Sachs Global Healthcare Conference June 9, 2025 10:40 AM ETCompany ...